By designating a single reference listed drug given that the typical to which all generic versions should be proven to be bioequivalent, FDA hopes to stay away from probable considerable versions among generic drugs and their brand name name counterpart. Quoted prices are for cash-spending customers and are not legitimate with insurance designs.